Monday, December 23, 2024
HomeTagsOncology Drug Development

Oncology Drug Development

Avacta and Tempus Collaborate on AI-Driven Oncology Drug Development

Avacta Therapeutics, a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, announces the initiation...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics